Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab

François Maury, Caroline Dufrois, Nathalie Lambert, Mélisande Bourgoin‐Heck, Stéphanie Wanin

Open source

DOI
10.1111/pai.70523
Published
2026-11
Container
Pediatric Allergy and Immunology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/pai.70523,
  title = {Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab},
  author = {François Maury and Caroline Dufrois and Nathalie Lambert and Mélisande Bourgoin‐Heck and Stéphanie Wanin},
  year = {2026},
  journal = {Pediatric Allergy and Immunology},
  doi = {10.1111/pai.70523},
  url = {https://doi.org/10.1111/pai.70523}
}

RIS

TY  - JOUR
TI  - Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab
AU  - François Maury
AU  - Caroline Dufrois
AU  - Nathalie Lambert
AU  - Mélisande Bourgoin‐Heck
AU  - Stéphanie Wanin
PY  - 2026
JO  - Pediatric Allergy and Immunology
DO  - 10.1111/pai.70523
UR  - https://doi.org/10.1111/pai.70523
ER  - 

APA

Maury, F., Dufrois, C., Lambert, N., Bourgoin‐Heck, M., & Wanin, S. (2026). Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.70523

Source records